Meng Gao
Impact in
- Pharmacology top 10%
- Piperaceae Chemical and Biological Studies
-
- Intracerebral and Subarachnoid Hemorrhage Research
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- Traditional Chinese Medicine Analysis 3
-
- Retinoids in leukemia and cellular processes 2
- Co-authors
- Lianhong Yin (10 shared papers)Jinyong Peng (6 shared papers)Yan Qi (8 shared papers)Changyuan Wang (5 shared papers)Yanfang Ding (5 shared papers)Youwei Xu (5 shared papers)Xuan Wu (3 shared papers)Zongyi Xie (2 shared papers)
- Journals
- Pharmaceutical Development and Technology (4 papers)Pharmacological Research (2 papers)Biomedicine & Pharmacotherapy (2 papers)Oxidative Medicine and Cellular Longevity (2 papers)Frontiers in Pharmacology (2 papers)
- Partner nations
- China
In The Last Decade
Meng Gao
31 papers receiving 535 citations
Peers
Comparison fields: 5 of 83
- Pharmacology 63
- Neurology 43
- Complementary and alternative medicine 34
- Pharmaceutical Science 23
- Biomaterials 51
Countries citing papers authored by Meng Gao
This map shows the geographic impact of Meng Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng Gao more than expected).
Fields of papers citing papers by Meng Gao
This network shows the impact of papers produced by Meng Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng Gao. The network helps show where Meng Gao may publish in the future.
Co-authors
The 25 scholars most cited alongside Meng Gao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 81 | |
| 2 | 2018 | 59 | |
| 3 | 2021 | 45 | |
| 4 | 2022 | 39 | |
| 5 | 2020 | 35 | |
| 6 | 2020 | 34 | |
| 7 | 2019 | 33 | |
| 8 | 2020 | 29 | |
| 9 | 2020 | 29 | |
| 10 | 2020 | 23 | |
| 11 | 2016 | 19 | |
| 12 | 2019 | 19 | |
| 13 | 2020 | 19 | |
| 14 | 2020 | 12 | |
| 15 | 2020 | 8 | |
| 16 | 2022 | 8 | |
| 17 | 2022 | 6 | |
| 18 | 2020 | 6 | |
| 19 | 2020 | 6 | |
| 20 | 2024 | 5 |
About Meng Gao
Meng Gao is a scholar working on Complementary and alternative medicine, Molecular Biology, Biomaterials, Nephrology and Cancer Research, having authored 31 papers that have together received 541 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (3 papers), Traditional Chinese Medicine Analysis (3 papers), MicroRNA in disease regulation (3 papers), Intracerebral and Subarachnoid Hemorrhage Research (2 papers), Retinoids in leukemia and cellular processes (2 papers), Acute Kidney Injury Research (2 papers), Autophagy in Disease and Therapy (2 papers) and Porphyrin and Phthalocyanine Chemistry (2 papers). The work is most often cited by research in Pharmacology (63 citations), Neurology (43 citations), Complementary and alternative medicine (34 citations), Pharmaceutical Science (23 citations) and Biomaterials (51 citations). Meng Gao has collaborated with scholars based in China. Frequent co-authors include Lianhong Yin, Jinyong Peng, Yan Qi, Changyuan Wang, Yanfang Ding, Youwei Xu, Xuan Wu, Zongyi Xie, Yuan Cheng and Yingying Ding. Their work appears in journals such as Pharmaceutical Development and Technology, Pharmacological Research, Biomedicine & Pharmacotherapy, Oxidative Medicine and Cellular Longevity and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.